<DOC>
	<DOC>NCT00412854</DOC>
	<brief_summary>This study will compare GSK Biologicals' DTPa/Hib vaccine to separately administered DTPa and Hib vaccines in Chinese infants 3, 4 &amp; 5 months of age, in terms of safety and immunogenicity.</brief_summary>
	<brief_title>Study to Assess Safety &amp; Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.</brief_title>
	<detailed_description />
	<mesh_term>Diphtheria</mesh_term>
	<criteria>A male or female between, and including, 90 and 120 days of age at the time of the first vaccination, written informed consent obtained from the parent or guardian of the subject Subjects with known exposure to diphtheria, tetanus, pertussis and/or Haemophilus influenzae disease can not participate, Subjects who have received previous vaccination against diphtheria, tetanus, acellular pertussis and/or Haemophilus influenzae type b diseases can not participate.</criteria>
	<gender>All</gender>
	<minimum_age>90 Days</minimum_age>
	<maximum_age>120 Days</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>